Drug product selection by formulary committees in Sweden
Lilja, J.
American Journal of Hospital Pharmacy 36(8): 1042 1044
1979
ISSN/ISBN: 0002-9289 PMID: 484560 Document Number: 144829
Document emailed within 1 workday
Related Documents
Wang, Y.R.; Pauly, M.V. 2005: Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors Managed Care Interface 18(8): 39-45Dedrick, S.C.; Eckel, F.M. 1984: Assessment of vendors and drug-product selection American Journal of Hospital Pharmacy 41(4): 703-708
Smith, M.C. 1978: Information flows on a drug product selection bill American Journal of Pharmacy and the Sciences Supporting Public Health 150(2): 51-58
Ford, D.B.; Bergerson, S.L.; Henderson, P.; Murphy, J.; Peter, J. 1989: Establishing an enteral product formulary Journal of the American Dietetic Association 89(5): 681-683
DiPiro, J.T.; Steele, J.C. 1987: Rational formulary selection of antimicrobials American Journal of Hospital Pharmacy 44(1): 74
Keeffe, E.B.; Harper, J.M.; LeMay, A.; Sherrin, T.P.; Siepler, J.K. 1991: Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion Hospital Formulary 26 Suppl D: 13-19
Kraft, J.N.; Lynde, C.W. 2005: Moisturizers: what they are and a practical approach to product selection Skin Therapy Letter 10(5): 1-8
Burkhart, C.G. 2004: And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange Journal of Drugs in Dermatology: Jdd 3(1): 11
Swanson, D.P.; Dick, T.J.; Simms, S.M.; Thrall, J.H. 1985: Product selection criteria for intravascular ionic contrast media Clinical Pharmacy 4(5): 527-538
Allebeck, P. 2005: Drug committees are necessary, according to the SNS reference group Lakartidningen 102(14): 1070
Leung, T.I.; Dumontier, M. 2015: Comparing Drug-Disease Associations in Clinical Practice Guideline Recommendations and Drug Product Label Indications Studies in Health Technology and Informatics 216: 1039
Rane, A. 2006: Drug committees should not recommend "off label" prescriptions Lakartidningen 103(15-16): 1219
Asberg, K.Hulter. 2009: Drug committees' information leaflets are needed Lakartidningen 106(38): 2384
Leydon, J.J. 1968: Modern hospital purchasing. "Salesman's pass" aids security and product selection Modern Hospital 111(2): 54
Altunkaya, A. 2002: A practical guide to the selection and application of topical antimicrobials, from a product development perspective Karsa, D R , Reprint Author, Ashworth, D Industrial biocides: Selection and application: 156-161
Larsson, I.; Ferrándiz, R. 2008: The vast majority of drug committees recommend Anapen Lakartidningen 105(41): 2865
Rabøl, R.; Kampmann, J.Peter.; Christensen, H.R. 2004: Drug committees in Denmark. Status and future challenges Ugeskrift for Laeger 166(35): 2988-2991
Swenson, L.; Audell, L.; Hedhammar, A. 1997: Prevalence and inheritance of and selection for hip dysplasia in seven breeds of dogs in Sweden and benefit: cost analysis of a screening and control program Journal of the American Veterinary Medical Association 210(2): 207-214
Sedivý, J.; Setka, J.; Rusek, J. 1992: The role of ethics committees in evaluating the ethical aspects of clinical drug trials Casopis Lekaru Ceskych 131(17): 539-540
Swenson, L.; Audell, L.; Hedhammar, A. 1997: Prevalence and inheritance of and selection for elbow arthrosis in Bernese mountain dogs and Rottweilers in Sweden and benefit: cost analysis of a screening and control program Journal of the American Veterinary Medical Association 210(2): 215-221